Matches in SemOpenAlex for { <https://semopenalex.org/work/W3217340582> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W3217340582 endingPage "vi94" @default.
- W3217340582 startingPage "vi94" @default.
- W3217340582 abstract "Abstract OBJECTIVE Indoleamine 2,3-dioxygenase 1 (IDO; IDO1) is an immune checkpoint that’s characterized as a potent immunosuppressive mediator through its ability to metabolize tryptophan and wild-type IDH patient-resected glioblastoma (GBM) expresses IDO in ≥ 95% of cases. Recent findings from our group led us to investigate the alternative hypothesis that IDO possesses immunosuppressive effects that are independent of its associated metabolic activity. METHODS Murine GBM cell lines that overexpress either wild-type or enzyme-null IDO were created for in vivo characterization of IDO enzyme-independent immunosuppressive function. Microarray was conducted to identify human IDO expression-correlated genes, which were further investigated in human GBM cell lines, patient GBM tissues and plasma, as well as the TCGA database. Ex vivo cell co-culture assays and syngeneic mouse orthotopic GBM models were employed to study immunosuppressive mechanisms. RESULTS Here, we demonstrate that non-enzymic IDO activity decreases survival in experimental animals and increases the expression of immunosuppressive complement factor H (CFH) in human GBM. CFH mRNA levels positively correlate with those of IDO and many other immunosuppressive genes in patient resected GBM and can be applied as a prognostic marker in both lower grade gliomas and GBM. Similar to IDO, the increased expression of CFH in patient-resected glioma was positively correlated with an increased signature for regulatory T cells (Tregs) and myeloid-derived suppressive cells (MDSCs). High expression of CFH in tumor cells increases intratumoral Tregs levels and decreases overall survival in mice with GBM, while inducing tumor associated macrophage cell differentiation. CONCLUSIONS Here, we demonstrated that glioblastoma (GBM) cell IDO promotes the accumulation of intratumoral FoxP3+ regulatory T cells (Tregs) and tumor progression while decreasing overall survival - independent of IDO enzyme activity. Our study reveals a targetable non-metabolic IDO-dependent mechanism for future therapeutic intervention in patients with GBM." @default.
- W3217340582 created "2021-12-06" @default.
- W3217340582 creator A5008472386 @default.
- W3217340582 creator A5009670051 @default.
- W3217340582 creator A5012059897 @default.
- W3217340582 creator A5019501470 @default.
- W3217340582 creator A5022672574 @default.
- W3217340582 creator A5023866306 @default.
- W3217340582 creator A5026264123 @default.
- W3217340582 creator A5037497459 @default.
- W3217340582 creator A5039925480 @default.
- W3217340582 creator A5040284400 @default.
- W3217340582 creator A5042003100 @default.
- W3217340582 creator A5048556371 @default.
- W3217340582 creator A5049572543 @default.
- W3217340582 creator A5050603971 @default.
- W3217340582 creator A5063498900 @default.
- W3217340582 creator A5071101610 @default.
- W3217340582 creator A5074788911 @default.
- W3217340582 creator A5074800269 @default.
- W3217340582 creator A5076095831 @default.
- W3217340582 creator A5078785815 @default.
- W3217340582 creator A5079762031 @default.
- W3217340582 creator A5082027834 @default.
- W3217340582 date "2021-11-02" @default.
- W3217340582 modified "2023-10-16" @default.
- W3217340582 title "IMMU-12. TUMOR CELL IDO ENHANCES IMMUNE SUPPRESSION AND DECREASES SURVIVAL INDEPENDENT OF TRYPTOPHAN METABOLISM IN GLIOBLASTOMA" @default.
- W3217340582 doi "https://doi.org/10.1093/neuonc/noab196.371" @default.
- W3217340582 hasPublicationYear "2021" @default.
- W3217340582 type Work @default.
- W3217340582 sameAs 3217340582 @default.
- W3217340582 citedByCount "1" @default.
- W3217340582 countsByYear W32173405822022 @default.
- W3217340582 crossrefType "journal-article" @default.
- W3217340582 hasAuthorship W3217340582A5008472386 @default.
- W3217340582 hasAuthorship W3217340582A5009670051 @default.
- W3217340582 hasAuthorship W3217340582A5012059897 @default.
- W3217340582 hasAuthorship W3217340582A5019501470 @default.
- W3217340582 hasAuthorship W3217340582A5022672574 @default.
- W3217340582 hasAuthorship W3217340582A5023866306 @default.
- W3217340582 hasAuthorship W3217340582A5026264123 @default.
- W3217340582 hasAuthorship W3217340582A5037497459 @default.
- W3217340582 hasAuthorship W3217340582A5039925480 @default.
- W3217340582 hasAuthorship W3217340582A5040284400 @default.
- W3217340582 hasAuthorship W3217340582A5042003100 @default.
- W3217340582 hasAuthorship W3217340582A5048556371 @default.
- W3217340582 hasAuthorship W3217340582A5049572543 @default.
- W3217340582 hasAuthorship W3217340582A5050603971 @default.
- W3217340582 hasAuthorship W3217340582A5063498900 @default.
- W3217340582 hasAuthorship W3217340582A5071101610 @default.
- W3217340582 hasAuthorship W3217340582A5074788911 @default.
- W3217340582 hasAuthorship W3217340582A5074800269 @default.
- W3217340582 hasAuthorship W3217340582A5076095831 @default.
- W3217340582 hasAuthorship W3217340582A5078785815 @default.
- W3217340582 hasAuthorship W3217340582A5079762031 @default.
- W3217340582 hasAuthorship W3217340582A5082027834 @default.
- W3217340582 hasBestOaLocation W32173405821 @default.
- W3217340582 hasConcept C203014093 @default.
- W3217340582 hasConcept C2776706248 @default.
- W3217340582 hasConcept C2777702733 @default.
- W3217340582 hasConcept C2778227246 @default.
- W3217340582 hasConcept C502942594 @default.
- W3217340582 hasConcept C515207424 @default.
- W3217340582 hasConcept C55493867 @default.
- W3217340582 hasConcept C83478079 @default.
- W3217340582 hasConcept C86803240 @default.
- W3217340582 hasConcept C8891405 @default.
- W3217340582 hasConceptScore W3217340582C203014093 @default.
- W3217340582 hasConceptScore W3217340582C2776706248 @default.
- W3217340582 hasConceptScore W3217340582C2777702733 @default.
- W3217340582 hasConceptScore W3217340582C2778227246 @default.
- W3217340582 hasConceptScore W3217340582C502942594 @default.
- W3217340582 hasConceptScore W3217340582C515207424 @default.
- W3217340582 hasConceptScore W3217340582C55493867 @default.
- W3217340582 hasConceptScore W3217340582C83478079 @default.
- W3217340582 hasConceptScore W3217340582C86803240 @default.
- W3217340582 hasConceptScore W3217340582C8891405 @default.
- W3217340582 hasIssue "Supplement_6" @default.
- W3217340582 hasLocation W32173405821 @default.
- W3217340582 hasOpenAccess W3217340582 @default.
- W3217340582 hasPrimaryLocation W32173405821 @default.
- W3217340582 hasRelatedWork W1217682272 @default.
- W3217340582 hasRelatedWork W1447489530 @default.
- W3217340582 hasRelatedWork W1974427279 @default.
- W3217340582 hasRelatedWork W2027527855 @default.
- W3217340582 hasRelatedWork W2034707118 @default.
- W3217340582 hasRelatedWork W2049646220 @default.
- W3217340582 hasRelatedWork W2061395079 @default.
- W3217340582 hasRelatedWork W2220882815 @default.
- W3217340582 hasRelatedWork W2356902401 @default.
- W3217340582 hasRelatedWork W3028948306 @default.
- W3217340582 hasVolume "23" @default.
- W3217340582 isParatext "false" @default.
- W3217340582 isRetracted "false" @default.
- W3217340582 magId "3217340582" @default.
- W3217340582 workType "article" @default.